Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on December 26, 2007. The report details two significant corporate events: a modification to an existing loan agreement and an extension of a strategic alliance.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt levels, or liquidity ratios. The report focuses exclusively on contractual agreements rather than financial performance data.
Material Changes and Agreements
- Loan Modification: On December 26, 2007, the Company entered into a Fourth Loan Modification Agreement with Silicon Valley Bank. This agreement modifies the terms of the Loan and Security Agreement dated April 30, 2004. The Company stated it was in compliance with all covenants under the original agreement, and the modification was made to favorably amend certain terms.
- Strategic Alliance Extension: On December 20, 2007, the Company extended its strategic alliance with Philips Medical Systems on an interim basis until March 1, 2008. This extension allows both parties time to negotiate a new agreement to govern the alliance thereafter.
Outlook, Risks, and Management Commentary
Management commentary is limited to the rationale for the loan modification, noting the Company's compliance status and the favorable nature of the amended terms. The interim extension of the Philips alliance indicates ongoing negotiations for a long-term governance structure. No specific risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Verify the specific terms favorably amended in the Fourth Loan Modification Agreement with Silicon Valley Bank.
- Monitor the outcome of negotiations between Stereotaxis and Philips Medical Systems following the March 1, 2008 interim deadline.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K does not contain them.